On March 15, Shan Dong Kexing Bioproducts Co.Ltd(688136) announced that the company plans to set up a holding subsidiary, Shenzhen Kexing animal protection Biotechnology Co., Ltd., with a registered capital of 10.909 million yuan and a business scope of animal vaccine research and development.
According to the announcement, Shan Dong Kexing Bioproducts Co.Ltd(688136) signed the cooperation agreement on the joint venture establishment of Shenzhen Kexing animal protection Biotechnology Co., Ltd. with Fu Jun and Ma Jingyun, and Shan Dong Kexing Bioproducts Co.Ltd(688136) , Fu Jun and Ma Jingyun jointly funded the establishment of Shenzhen Kexing animal protection Biotechnology Co., Ltd. Of which, Shan Dong Kexing Bioproducts Co.Ltd(688136) invested and held 55% shares in cash of 6 million yuan; Fu Jun and Ma Jingyun contributed with intangible assets, holding 45% of the shares in total.
Shan Dong Kexing Bioproducts Co.Ltd(688136) said that the purpose of this foreign investment is to carry out research and development activities related to animal vaccines, make full use of the company’s rich experience and advantageous position in the field of biomedicine, seize the opportunity of biotechnology development, promote the company’s overall development strategy, better optimize the company’s resource allocation and enhance the company’s core competitiveness.
